Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 25 Rectal Neoplasms 23 Glioblastoma 23 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Breast Neoplasms 17 Pancreatic Neoplasms 16 Lung Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 14 Head and Neck Neoplasms 14 Neoplasms 12 Oropharyngeal Neoplasms 11 Neoplasm Metastasis 10 Esophageal Squamous Cell Carcinoma 9 Adenocarcinoma Of Esophagus 8 Uterine Cervical Neoplasms 7 Glioma 7 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Gliosarcoma 6 Carcinoma, Squamous Cell 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Melanoma 5 Laryngeal Neoplasms 5 Colorectal Neoplasms 5 Xerostomia 4 Sarcoma 4 Mouth Neoplasms 4

Interventions

Nivolumab 3 palbociclib 2 Ipilimumab 2 Imatinib Mesylate 2 relatlimab 1 pembrolizumab 1 camrelizumab 1 apatinib 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Protons 1 Proton Therapy 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Disulfides 1 Dasatinib 1 Cetuximab 1 CTLA-4 Antigen 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chordoma × Radiation × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡